Dept. of the Army -- USAMRAA logo

DoW Lung Cancer Translational Research Award

Dept. of the Army -- USAMRAA

Funding Amount

$9,100,000 total

Deadline

September 2, 2026

93 days left

Grant Type

federal

Overview

DoW Lung Cancer Translational Research Award

Summary: The fiscal year 2026 (FY26) Lung Cancer Research Program (LCRP) Translational Research Award (TRA) supports advanced translational research that will foster transformation of promising ideas in lung cancer into clinical applications. Research must address at least one of the FY26 LCRP areas of emphasis. Distinctive Features: This funding mechanism intends to support a broad range of translational studies and allows application submission under: Funding Level 1 – Advanced/late-stage preclinical work or correlative studies; or Funding Level 2 – Pilot clinical trials of novel interventions.

Details

  • Agency: Dept. of the Army -- USAMRAA
  • Department: Department of Defense
  • Opportunity #: HT942526LCRPTRA
  • Total Funding: $9,100,000
  • Expected Awards: 6
  • Instrument: grant

Eligibility

Eligible Applicant Types

unrestricted

Focus Areas & Funding Uses

Fields of Work

science-researchcancer

Categories

Browse similar grants by category

Related Grants

Similar grants from this funder and related organizations

Ready to apply for DoW Lung Cancer Translational Research Award?

Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.

You found DoW Lung Cancer Translational Research Award. Now let's win it.

Start writing